| Ocular drug delivery barriers—role of nanocarriers in the treatment of anterior segment ocular diseases RD Bachu, P Chowdhury, ZHF Al-Saedi, PK Karla, SHS Boddu Pharmaceutics 10 (1), 28, 2018 | 299 | 2018 |
| Dry eye disease: present challenges in the management and future trends Z Al-Saedi, A Zimmerman, R Devi Bachu, S Dey, Z Shah, R Baugh, ... Current pharmaceutical design 22 (28), 4470-4490, 2016 | 58 | 2016 |
| Ocular drug delivery barriers—role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics 10: 28 RD Bachu, P Chowdhury, ZHF Al-Saedi, PK Karla, SHS Boddu | 31 | 2018 |
| Formulation and In Vitro Evaluation of Cyclosporine-A Inserts Prepared Using Hydroxypropyl Methylcellulose for Treating Dry Eye Disease ZHF Al-Saedi, RM Alzhrani, SHS Boddu Journal of Ocular Pharmacology and Therapeutics 32 (7), 451-462, 2016 | 20 | 2016 |
| Formulation and characterization of oleogel as a topical carrier of azithromycin ZHF Al-Saedi, ZT Salih, KK Ahmed, RA Ahmed, SA Jasim AAPS PharmSciTech 24 (1), 17, 2022 | 4 | 2022 |
| Formulation and in vitro evaluation of cyclosporine A inserts prepared using HPMC for treating dry eye disease ZHF Al-Saedi University of Toledo, 2016 | | 2016 |
